Filters

Tranexamic acid manufacturers

Filters

Filters

Filters , active

Country of origin : Indonesia
None products found

tranexamic acid

Ampoules, injection 50 mg/ml, 100 mg/ml - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
EU GMP
Unavailable markets
Philippines , Thailand
Registered in
Austria , Croatia , Thailand
Available for
Licensing with supply, Distribution only
Manufacturer #559
This pharmaceutical company, operating for over a decade in the European market, focuses on providing cost-effective, high-quality drugs. They cater to both the medical community and patients, offering a range of products and trusted medical information. Their commitment to quality is evident in their adherence to EU GMP standards. While the company's website doesn't delve into specific therapy areas, their mission suggests a focus on delivering essential medications across various medical needs. Their production lines include both prescription and over-the-counter medications, available in various dosage forms such as solids, liquids, and injectables. Although specific product patents aren't explicitly mentioned, their dedication to providing novel products hints at ongoing research and development efforts.

Manufacturer usually replies in 28 days

tranexamic acid

Tablets 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20691

This CTD dossier owner and manufacturer, operating for over four decades in Southeast Asia, focuses on providing a wide range of healthcare solutions. Their product portfolio encompasses Rx (prescription) and OTC (over-the-counter) pharmaceuticals, medical devices, and nutraceuticals. Key therapy areas include dermatology, general health, and infection control. The company manufactures various dosage forms, including solids, liquids, and injectables. Their production facilities adhere to stringent EU and US GMP standards, demonstrating their commitment to quality and safety. The company's online platform facilitates convenient access to its products and information. They also offer toll manufacturing services and act as marketing authorization holders for other companies.

Manufacturer usually replies in 17 days

tranexamic acid

Tablets 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20666

This CTD dossier owner and manufacturer, established in the early 1970s in Southeast Asia, specializes in the production of prescription and over-the-counter medications, as well as food supplements. They offer a comprehensive range of dosage forms, including solids, liquids, and semi-solids. The company has a dedicated beta-lactam facility, specializing in the production of penicillin and cephalosporin antibiotics. Their portfolio encompasses over 200 brands, covering diverse therapeutic areas, with a strong focus on providing high-quality products at affordable prices. The company prioritizes adherence to national and international pharmacopoeia standards, ensuring the safety, efficacy, and quality of all their products. Their commitment to research and development ensures they can continuously meet evolving customer needs.

Manufacturer usually replies in 17 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Tranexamic acid is a coagulation modifier class medication that is used to prevent blood loss after major trauma, factor IX deficiency, hemophilia type A, melasma, nosebleeds, menorrhagia, and menstrual disorders. Manufacturing companies produce it as both standalone medication and in combination drug formulations, along with ingredients such as etamsylate and mefenamic acid. Suppliers market it in the forms of 100mg/ml solution for intravenous injection and 500mg tablets. In use for over 50 years, tranexamic acid is an inexpensive and widely used treatment. The World Health Organisation has included it in its list of Essential Medicines that contains the safest and most effective drugs recommended for a health system. Major pharmaceutical manufacturers and supplies of tranexamic acid include Pfizer and Sanofi-Aventis. Tranexamic acid is available in both trade name and generic formulations. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.